Maria José Campagnole-Santos Selected Research

7-Ala-angiotensin (1-7)

12/2020	Different reactive species modulate the hypotensive effect triggered by angiotensins at CVLM of 2K1C hypertensive rats.
10/2009	Angiotensin-(1-7) antagonist, A-779, microinjection into the caudal ventrolateral medulla of renovascular hypertensive rats restores baroreflex bradycardia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Maria José Campagnole-Santos Research Topics

Disease

6	Insulin Resistance 09/2018 - 10/2012
5	Hypertension (High Blood Pressure) 01/2021 - 06/2012
3	Pneumonia (Pneumonitis) 01/2021 - 12/2016
3	Inflammation (Inflammations) 01/2021 - 08/2013
3	Renovascular Hypertension (Goldblatt Syndrome) 12/2020 - 03/2013
3	Body Weight (Weight, Body) 01/2018 - 08/2013
3	Hypertrophy 08/2015 - 06/2012
3	Cardiomegaly (Heart Hypertrophy) 11/2014 - 05/2004
2	Asthma (Bronchial Asthma) 01/2021 - 12/2016
2	Necrosis 01/2019 - 08/2013
2	Bradycardia 02/2012 - 10/2009
1	COVID-19 07/2021
1	Human Influenza (Influenza) 01/2021
1	Pneumococcal Infections 01/2021
1	Fibrosis (Cirrhosis) 01/2019
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 01/2019
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 09/2018
1	Atherosclerosis 01/2018
1	Hyperthyroidism 01/2018
1	Mental Disorders (Mental Disorder) 01/2016
1	Diastolic Heart Failure 08/2015
1	Non-alcoholic Fatty Liver Disease 09/2013
1	Sclerosis 09/2013
1	Myocardial Infarction 06/2012
1	Heart Injuries 06/2012
1	Shock 01/2012
1	Infections 01/2012
1	Parasitemia 01/2012

Drug/Important Bio-Agent (IBA)

9	angiotensin I (1-7)IBA 07/2021 - 10/2009
7	Glucose (Dextrose)FDA LinkGeneric 09/2018 - 10/2012
4	alamandineIBA 01/2020 - 01/2018
3	salicylhydroxamic acid (SHAM)IBA 11/2014 - 10/2009
3	Triglycerides (Triacylglycerol)IBA 09/2013 - 08/2013
2	Angiotensin IIIBA 07/2021 - 10/2012
2	OvalbuminIBA 01/2021 - 12/2016
2	7-Ala-angiotensin (1-7)IBA 12/2020 - 10/2009
2	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2020 - 10/2012
2	SaltsIBA 09/2018 - 06/2012
2	Proteins (Proteins, Gene)FDA Link 01/2018 - 11/2014
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2018 - 02/2012
2	Peptides (Polypeptides)IBA 01/2018 - 10/2009
2	Desoxycorticosterone Acetate (DOCA)FDA Link 08/2015 - 06/2012
2	HDL CholesterolIBA 09/2013 - 09/2013
2	CholesterolIBA 09/2013 - 08/2013
2	Isoproterenol (Isoprenaline)FDA LinkGeneric 06/2012 - 05/2004
1	LipopolysaccharidesIBA 01/2021
1	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2019
1	CollagenIBA 01/2019
1	Matrix Metalloproteinases (MMPs)IBA 01/2019
1	Insulin (Novolin)FDA Link 08/2018
1	EnzymesIBA 01/2018
1	Triiodothyronine (Liothyronine)FDA LinkGeneric 01/2018
1	CytokinesIBA 12/2016
1	ChemokinesIBA 12/2016
1	MineralocorticoidsIBA 08/2015
1	CalciumIBA 11/2014
1	Messenger RNA (mRNA)IBA 11/2014
1	LipidsIBA 05/2014
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 09/2013
1	Alanine Transaminase (SGPT)IBA 09/2013
1	Transaminases (Aminotransferases)IBA 08/2013
1	Aspartic Acid (Aspartate)FDA Link 08/2013
1	Tumor Biomarkers (Tumor Markers)IBA 08/2013
1	Interleukin-6 (Interleukin 6)IBA 08/2013
1	AVE 0991IBA 03/2013
1	Biological ProductsIBA 10/2012
1	Urethane (Ethyl Carbamate)IBA 02/2012
1	NG-Nitroarginine Methyl Ester (L-NAME)IBA 02/2012
1	Oxidoreductases (Dehydrogenase)IBA 01/2012
1	NitratesIBA 01/2012
1	NADP (NADPH)IBA 01/2012
1	Superoxides (Superoxide)IBA 01/2012
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2012
1	4- ethoxymethylene- 2- phenyl- 2- oxazoline- 5- one (phOx)IBA 01/2012
1	NitritesIBA 01/2012
1	AngiotensinsIBA 10/2009
1	Losartan (Cozaar)FDA LinkGeneric 10/2009

Therapy/Procedure

2	Therapeutics 01/2019 - 01/2016
1	Oral Administration 01/2021
1	Injections 01/2018
1	Aftercare (After-Treatment) 08/2015